Window of Opportunity Study of Preoperative Immunotherapy With Atezolizumab in Local SCCHN

NCT04939480 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Squamous Cell Carcinoma of Head and Neck

Interventions

DRUG: Atezolizumab

Sponsor

University Hospital, Essen